Press/Media
- 1 - 25 out of 2,124 results
Search results
-
Weekly: Collegium Pharmaceutical (COLL: $29.66) falls for a fourth consecutive week, a four-week fall of 11%; -$1.16 [3.8%]
15/02/25
1 item of Media coverage
Press/Media
-
Weekly: Abivax S.A (ABVX: $7.40) soars 17% on below average volume; +$1.10 [17.5%]
Zhang, D., Sands, B. E. & Dubinsky, M.
15/02/25
1 item of Media coverage
Press/Media
-
Abivax S.A decreases 2.0% in 2025
Zhang, D., Sands, B. E. & Dubinsky, M.
14/02/25
1 item of Media coverage
Press/Media
-
Collegium Pharmaceutical climbs 8.1% in 2025, outperforming Medical/Drugs sector
14/02/25
1 item of Media coverage
Press/Media
-
New Curriculum for the Master of Science in Biomedical Science Program Provides More Options for Students
12/02/25
1 item of Media coverage
Press/Media
-
-
Weekly: Collegium Pharmaceutical (COLL: $30.82) falls for a third consecutive week, a three-week fall of 8%; -$1.30 [4.0%]
8/02/25
1 item of Media coverage
Press/Media
-
Weekly: Abivax S.A (ABVX: $6.30) climbs 5.5%, 2 weeks' volume in a week; +33c [5.5%] Vol Index 2.2 [1 is avg]
Zhang, D., Sands, B. E. & Dubinsky, M.
8/02/25
1 item of Media coverage
Press/Media
-
-
Abivax S.A plummets 55% in past year, underperforming 83% of the market
Zhang, D., Sands, B. E. & Dubinsky, M.
4/02/25
1 item of Media coverage
Press/Media
-
-
NCAA WOMEN’S LACROSSE: UAlbany excited for opening challenge at No. 6 Syracuse
4/02/25
2 items of Media coverage
Press/Media
-
Monthly: Collegium Pharmaceutical (COLL: $32.12) jumps 12% on thin volume in January 2025
3/02/25
1 item of Media coverage
Press/Media
-
Monthly: Abivax S.A (ABVX: $5.97) falls for a fourth consecutive month, a four-month fall of 48%
Zhang, D., Sands, B. E. & Dubinsky, M.
3/02/25
1 item of Media coverage
Press/Media
-
Town writes letter to Executive Office of Housing and Livable Communities in support of Waterfield lot project
28/01/25
2 items of Media coverage
Press/Media
-
Weekly: Abivax S.A (ABVX: $6.09) falls for a third consecutive week, a three-week fall of 18%; -7c [1.1%]
Zhang, D., Sands, B. E. & Dubinsky, M.
25/01/25
1 item of Media coverage
Press/Media
-
Weekly: Collegium Pharmaceutical (COLL: $32.59) drops 2.3% on weak volume; -76c [2.3%]
25/01/25
1 item of Media coverage
Press/Media
-
Females Have a 31% Higher Associated Risk of Developing Long COVID, UT Health San Antonio-led RECOVER Study Shows
Zhang, D., Bartram, L., Charney, A. & Lin, J.
23/01/25
1 item of Media coverage
Press/Media
-
Females have a 31% higher associated risk of developing long COVID, UT Health San Antonio-led RECOVER study shows
Zhang, D., Bartram, L., Charney, A. & Lin, J.
23/01/25
1 item of Media coverage
Press/Media
-
Females have a 31% higher associated risk of developing long COVID, UT Health San Antonio-led RECOVER study shows
Zhang, D., Bartram, L., Charney, A. & Lin, J.
22/01/25
73 items of Media coverage
Press/Media
-
UT Health San Antonio: Females have a 31% higher associated risk of developing long COVID
Zhang, D., Bartram, L., Charney, A. & Lin, J.
22/01/25
1 item of Media coverage
Press/Media
-
Females have a 31% higher associated risk of developing long COVID, UT Health San Antonio-led RECOVER study shows
Zhang, D., Bartram, L., Charney, A. & Lin, J.
22/01/25
1 item of Media coverage
Press/Media
-
Researchers at Icahn School of Medicine at Mount Sinai Target Melanoma (H2a.z Chaperones Converge On E2f Target Genes for Melanoma Cell Proliferation)
Jostes, S., Singh, R., Bernstein, E., Phelps, R. & Grossi, E.
21/01/25
1 item of Media coverage
Press/Media
-
Weekly: Collegium Pharmaceutical (COLL: $33.14) keeps rising: up 14% in 3 weeks; +23c [0.7%]
18/01/25
1 item of Media coverage
Press/Media